Bone marrow fat and skeletal health in type 2 diabetes

2 型糖尿病患者的骨髓脂肪和骨骼健康

基本信息

项目摘要

Dr. Kim’s long-term goal is to be a VA physician investigator, elucidating mechanisms of diabetic bone disease in order to reduce fracture risk in people with diabetes. There is growing recognition that bone disease is a complication of type 2 diabetes mellitus (T2DM). In T2DM, hip fracture risk is increased by more than a third, and after fracture, individuals with T2DM have higher rates of postoperative complications and a higher risk of mortality. Fracture risk is elevated even after controlling for falls, and hip fractures occur despite preserved or higher bone mineral density (BMD). The fat within the bone marrow is proposed to play a pathogenic role in diabetic bone disease, as fat and bone are intimately related within the marrow microenvironment. Adipocytes and osteoblasts share a common mesenchymal stem cell precursor, and adipogenesis could occur at the expense of osteoblastogenesis. Indeed, greater levels of marrow fat content are associated with lower BMD and higher fracture risk. However, it is unknown whether marrow fat can be manipulated to improve diabetic bone disease. Hemoglobin A1c (HbA1c) positively correlates with higher levels of marrow fat, so enhanced glycemic control might normalize marrow fat and improve bone outcomes. Given the widespread prevalence of diabetes and the medical and economic costs of fractures, there is an urgent need to understand diabetic bone disease to identify targeted preventive and therapeutic strategies. During the Career Development Award-2 (CDA-2) period, Dr. Kim’s goal is to acquire the training and implement the studies needed to understand the effects of improved glycemic control on marrow fat and bone health. She will gain expertise in valuable clinical research and translational methods that will position her to become a leader in the field of diabetic bone disease. Dr. Kim will enroll and follow 75 Veterans with poorly controlled T2DM (HbA1c 8.5-12.0%) who are working with their clinicians to improve glycemic control. She will determine the effects of improved glycemic control on bone marrow fat (Aim 1) and the relationship between changes in marrow fat with bone quality and mass (Aim 2). Pursuit of these aims will involve critical training in the design and implementation of a prospective cohort study. Dr. Kim will use advanced and sensitive imaging modalities (including magnetic resonance spectroscopy, high-resolution peripheral quantitative computed tomography) to assess marrow fat and bone outcomes at baseline and then after 1 year of intensified medical management. Dr. Kim will also use cutting edge translational methods to explore the role of osteoblast differentiation as a pathway linking marrow fat and bone outcomes (Aim 3). This will include characterizing circulating osteoblast progenitor cells by flow cytometry and evaluating expression of osteoblast differentiation genes. Training in advanced diabetes and lipid metabolism will allow Dr. Kim to interpret these findings and gain important insights into the pathogenesis of diabetic bone disease. This research is expected to advance understanding of marrow fat behavior, which may lead to targeted preventive and therapeutic strategies for diabetic bone disease and osteoporosis. Dr. Kim has assembled a diverse mentorship team comprised of experts in osteoporosis, metabolism, epidemiology, biostatistics, and radiology. Her training will involve a combination of individual tutorials with her mentors and scientific advisors, hands-on experience, and formal coursework. The proposed research will provide Dr. Kim with preliminary data for a larger and longer-term prospective study of diabetic bone disease, which she will propose in a Merit Review application submitted before the end of the CDA-2 period. Dr. Kim is committed to improving the health care of Veterans through clinical research, and with her proposed research and training, she will develop a thriving research program at the VA.
金博士的长期目标是成为一名退伍军人事务部医生调查员,阐明糖尿病骨的机制。 为了降低糖尿病患者的骨折风险,人们越来越认识到, 是2型糖尿病(T2 DM)的并发症。在T2 DM中,髋部骨折的风险增加超过 第三,骨折后,T2 DM患者的术后并发症发生率较高, 死亡风险。即使在控制了福尔斯跌倒后,骨折的风险也会升高, 保持或更高的骨矿物质密度(BMD)。骨髓中的脂肪被认为是 糖尿病骨病的致病作用,因为脂肪和骨骼在骨髓中密切相关 微环境脂肪细胞和成骨细胞具有共同的间充质干细胞前体, 脂肪形成可能以成骨细胞形成为代价而发生。事实上,更高水平的骨髓脂肪含量 与较低的BMD和较高的骨折风险相关。然而,骨髓脂肪是否可以 用来改善糖尿病性骨病血红蛋白A1 c(HbA 1c)与较高的 因此,加强血糖控制可能会使骨髓脂肪正常化并改善骨骼结果。 考虑到糖尿病的广泛流行以及骨折的医疗和经济成本, 迫切需要了解糖尿病性骨病,以确定有针对性的预防和治疗策略。 在职业发展奖-2(CDA-2)期间,金博士的目标是获得培训, 开展研究,了解改善血糖控制对骨髓脂肪和骨骼的影响 健康她将获得宝贵的临床研究和转化方法的专业知识,这将使她能够 成为糖尿病骨病领域的领导者。金博士将招募并跟踪75名退伍军人, 受控制的T2 DM(HbA 1c 8.5-12.0%),他们正在与临床医生合作改善血糖控制。她将 确定改善血糖控制对骨髓脂肪的影响(目标1)以及 骨髓脂肪与骨质量和骨质量的变化(目的2)。追求这些目标将涉及以下方面的关键培训: 前瞻性队列研究的设计和实施。金博士将使用先进而灵敏的成像技术 模态(包括磁共振波谱、高分辨率外周定量计算 断层扫描),以评估基线时的骨髓脂肪和骨结局,然后在1年强化医疗后 管理金博士还将使用尖端的翻译方法来探索成骨细胞的作用, 分化作为连接骨髓脂肪和骨结果的途径(Aim 3)。这将包括表征 流式细胞术检测循环成骨细胞祖细胞并评估成骨细胞分化的表达 基因.高级糖尿病和脂质代谢方面的培训将使金博士能够解释这些发现, 对糖尿病性骨病的发病机制有重要的认识。这项研究有望取得进展 了解骨髓脂肪行为,这可能会导致有针对性的预防和治疗策略, 糖尿病性骨病和骨质疏松症。金博士组建了一个多元化的导师团队, 骨质疏松症、新陈代谢、流行病学、生物统计学和放射学方面的专家。她的训练将包括 结合个人教程与她的导师和科学顾问,动手经验,和正式的 课程作业拟议的研究将为Kim博士提供更大和更长期的初步数据。 糖尿病性骨病的前瞻性研究,她将在提交的Merit Review申请中提出 在CDA-2期间结束之前。金博士致力于改善退伍军人的医疗保健, 临床研究,并与她提出的研究和培训,她将制定一个蓬勃发展的研究计划,在 退伍军人事务部

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tiffany Youngun Kim其他文献

Tiffany Youngun Kim的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tiffany Youngun Kim', 18)}}的其他基金

Bone marrow fat and skeletal health in type 2 diabetes
2 型糖尿病患者的骨髓脂肪和骨骼健康
  • 批准号:
    10413813
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Bone marrow fat and skeletal health in type 2 diabetes
2 型糖尿病患者的骨髓脂肪和骨骼健康
  • 批准号:
    10657381
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:

相似国自然基金

相似海外基金

New development of cellular regeneration therapy in jaw bone using stem cells derived from adipocytes jaw bone
利用颌骨脂肪细胞来源的干细胞进行颌骨细胞再生治疗的新进展
  • 批准号:
    23K16058
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A novel mechanism of insulin resistance mediated by uric acid metabolism in adipocytes
脂肪细胞尿酸代谢介导胰岛素抵抗的新机制
  • 批准号:
    23K10969
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Hypertrophic adipocytes as biophysical mediators of breast cancer progression
肥大脂肪细胞作为乳腺癌进展的生物物理介质
  • 批准号:
    10751284
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Elucidation of mechanisms for conversion of adipocytes to cancer-associated fibroblasts in osteosarcoma microenvironment
阐明骨肉瘤微环境中脂肪细胞转化为癌症相关成纤维细胞的机制
  • 批准号:
    23K19518
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Study on UCP-1 independent metabolic regulation by brown adipocytes
棕色脂肪细胞对UCP-1独立代谢调节的研究
  • 批准号:
    23K18303
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Development of adipocytes for gene therapy that avoids cellular stress due to overexpression of therapeutic proteins
开发用于基因治疗的脂肪细胞,避免因治疗蛋白过度表达而造成的细胞应激
  • 批准号:
    23H03065
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functional analysis of bitter taste receptors in adipocytes and hepatocytes
脂肪细胞和肝细胞中苦味受体的功能分析
  • 批准号:
    23K05107
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
NKA/CD36 signaling in adipocytes promotes oxidative stress and drives chronic inflammation in atherosclerosis
脂肪细胞中的 NKA/CD36 信号传导促进氧化应激并驱动动脉粥样硬化的慢性炎症
  • 批准号:
    10655793
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
The mechanisms of the signal transduction from brown adipocytes to afferent neurons and its significance.
棕色脂肪细胞向传入神经元的信号转导机制及其意义。
  • 批准号:
    23K05594
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
NKT cell activation depend on lipid accumulation in adipocytes
NKT 细胞的激活取决于脂肪细胞中的脂质积累
  • 批准号:
    22K08679
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了